Hormone Receptor Negative Tumor clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
I-SPY TRIAL: Personalized Chemotherapy to Treat Different Types of Breast Cancer
open to eligible people ages 18 years and up
The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue and blood samples) are predictors of treatment success.
at UCSD UCSF
Our lead scientists for Hormone Receptor Negative Tumor research studies include Laura Esserman, MD, MBA.